Rangeley Capital, LLC ABUS β€” ARBUTUS BIOPHARMA CORP

Ownership history in Rangeley Capital, LLC  Β·  5 quarters on record

AI Ownership Summary

Rangeley Capital, LLC reported ARBUTUS BIOPHARMA CORP (ABUS) in 5 quarterly 13F filings from 2024 Q4 through 2025 Q4. Peak portfolio weight reached 5.04% in 2025 Q1. The latest visible filing shows ABUS at 3.36% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this ABUS ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Rangeley Capital, LLC's position in ARBUTUS BIOPHARMA CORP, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q4

ABUS was reported at 3.36% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
5.04% in 2025 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q4 to 2025 Q4

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

ABUS stock page Rangeley Capital, LLC fund profile Rangeley Capital, LLC full holdings
How Rangeley Capital, LLC held ABUS β€” position size vs. price
% of Fund (quarterly)    ABUS price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
πŸ“‹ Quarterly Holdings History 5 quarters  β–Ύ
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q4 UNCHANGED β€” β€” β€” 840,000 β€” 0% 3.36% $4.0M 2026-02-14 (Est.) $3.98
2025 Q3 REDUCED β€” β€” β€” 840,000 -25,000 -2.9% 3.30% $3.8M 2025-11-14 $4.52
2025 Q2 REDUCED 35.9% +44.3% ❌ 865,000 -484,000 -35.9% 3.19% $2.7M 2025-08-14 $3.37
2025 Q1 REDUCED 7.5% -11.5% βœ… 1,349,000 -110,000 -7.5% 5.04% $4.7M 2025-05-14 $3.16
2024 Q4 INITIATED β€” β€” β€” 1,459,000 β€” β€” 4.28% $4.8M 2025-02-12 $3.31

🏒 Other funds also holding ABUS

As of 2026 Q1 β€” sorted by position size

Western Standard LLC 3Y 7Y 1.23% Ledgewood Wealth Advisors, LLC 0.71% Carrera Capital Advisors 0.17% WMG Financial Advisors, LLC 3Y 0.02% Premier Path Wealth Partners, LLC 0.02% Abel Hall, LLC 0.02% China Universal Asset Management Co., Ltd. 3Y 0.01% PROFUND ADVISORS LLC 3Y 7Y 0.01% Clear Harbor Asset Management, LLC 3Y 7Y 0.01% SBI Securities Co., Ltd. 0.0%

FAQ About Rangeley Capital, LLC and ABUS

These are the practical questions this page is built to answer before you even open the full history table.

How long has Rangeley Capital, LLC reported owning ABUS?

Rangeley Capital, LLC reported ABUS across 5 quarterly 13F filings, from 2024 Q4 through 2025 Q4.

What was the largest reported ABUS position in Rangeley Capital, LLC's portfolio?

The largest reported portfolio weight for ABUS was 5.04% in 2025 Q1.

What is the latest reported ABUS position on this page?

The most recent filing on this page is 2025 Q4, when Rangeley Capital, LLC reported 840,000 shares, equal to 3.36% of portfolio, with an estimated market value of $4.0M.

What does the chart on this ABUS ownership page compare?

The chart compares Rangeley Capital, LLC's quarterly ABUS portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Rangeley Capital, LLC time their ABUS position?

Based on 13F filing dates vs. subsequent ABUS price moves, Rangeley Capital, LLC correctly timed 1 out of 4 reported position changes (25%). The annualised alpha on ABUS relative to SPY over the holding period was +5.2%.

← Back to Rangeley Capital, LLC Holdings